Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review: Psychopharmacological treatment for military PTSD
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
PURPOSE: Posttraumatic stress disorder (PTSD) is a serious mental health disorder. The current first-line psychopharmacologic treatment for PTSD is selective serotonin reuptake inhibitors (SSRIs). Recently, the efficacy of SSRIs has been challenged in favor of propranolol use. This article reviews the origins of PTSD, its impact within the veteran population, psychopharmacological treatment of PTSD, and current literature on the use of propranolol for PTSD treatment. DATA SOURCES: The search strategies used included ProQuest, Medline, CINAHL, and Psychiatry Online and were searched using the key terms: PTSD, psychopharmacological treatment, SSRIs, propranolol, military, and veterans in multiple combinations. CONCLUSIONS: Studies to date indicate that (a) SSRIs are only moderately effective as a first-line treatment for PTSD and less so for military personnel, (b) propranolol has the ability to attenuate traumatic memory in primary and tertiary use, and (c) ethical and moral consideration as well as further research and testing is needed for substantiating propranolol as a first-line PTSD psychopharmacological treatment. IMPLICATIONS FOR PRACTICE: Current research has shown propranolol to be an effective treatment option for PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Dębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602
Brunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548 · cited 2×
“Brunet et al. (2008) tested the retrieval of a past traumatic event and a window of vulnerable plasticity, where a β-adrenergic inhibitor would block the neurotransmission of the trauma encoding stress hormones associated with PTSD and reduce the memory’s emotional and physiologic impact despite…”
BackgroundMethodImmediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499 · cited 5×
“Pitman et al. (2002) and Vaiva et al. (2003) used Emergency Department patients as their subjects and administered oral propranolol to subjects within 6 h of the traumatic event and continued treatment for 7–10 days.”
BackgroundMethodInfluentialPharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.004 · Cited by 347
Neurobiology of PTSD: A Review of Neuroimaging Findings
Garfinkel, S. N., & Liberzon, I. (2009) · Psychiatric Annals · doi:10.3928/00485713-20090527-01 · Cited by 102 · cited 1×
“Evers (2007), Antai-Otong (2007), Garfinkel and Liberzon (2009), Mirkes (2010), and Robinson and Shergill (2011) examined the differences between people who experienced similar traumatic events and found that individuals who are vulnerable to PTSD have structural abnormalities of the brain,…”
Background
Cited by
Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137
Circuit dysregulation and circuit-based treatments in posttraumatic stress disorder
Sheynin, J., & Liberzon, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.014 · Cited by 68
“Both sertraline and paroxetine had been FDA approved for PTSD treatment [63], however, they were developed initially as “me too” products, and while some hypothetical links to specific circuits can be proposed (see below), there are no sufficient empirical data to link their efficacy to a specific neural circuitry.”
BackgroundSzeleszczuk, Ł., & Frączkowski, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710099 · Cited by 46
Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders
Venero, C. (2015) · Cognitive Enhancement · doi:10.1016/b978-0-12-417042-1.00010-3 · Cited by 4
Metadata
- Authors
- Tawa, J., & Murphy, S.
- Venue
- Journal of the American Association of Nurse Practitioners
- Publisher
- Wiley
- Published
- 2013-03-06
- Volume
- 25
- Issue
- 8
- Pages
- 419-423
- ISSN
- 2327-6886 (ISSN-L)
- OpenAlex
- W1652584161
- Cited by
- 25
- References
- 6
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review: Psychopharmacological treatment for military PTSD. https://app.cochat.ai/papers/10.1111/1745-7599.12016
- The paper
- Tawa, J., & Murphy, S. (2013). Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review: Psychopharmacological treatment for military PTSD. Journal of the American Association of Nurse Practitioners. https://doi.org/10.1111/1745-7599.12016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.